Parametric Portfolio Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $21.4M | Buy |
|
|||||
|
2021
Q4 | $15.6M | Sell |
|
|||||
|
2021
Q3 | $21.7M | Buy |
|
|||||
|
2021
Q2 | $21.6M | Buy |
|
|||||
|
2021
Q1 | $17.7M | Buy |
|
|||||
|
2020
Q4 | $15.5M | Sell |
|
|||||
|
2020
Q3 | $17.8M | Buy |
|
|||||
|
2020
Q2 | $21.8M | Buy |
|
|||||
|
2020
Q1 | $14.9M | Buy |
|
|||||
|
2019
Q4 | $18M | Buy |
|
|||||
|
2019
Q3 | $11M | Buy |
|
|||||
|
2019
Q2 | $9.05M | Buy |
|
|||||
|
2019
Q1 | $8.06M | Buy |
|
|||||
|
2018
Q4 | $6.31M | Sell |
|
|||||
|
2018
Q3 | $13.7M | Buy |
|
|||||
|
2018
Q2 | $9.14M | Buy |
|
|||||
|
2018
Q1 | $6.78M | Buy |
|
|||||
|
2017
Q4 | $5.78M | Buy |
|
|||||
|
2017
Q3 | $3.69M | Buy |
|
|||||
|
2017
Q2 | $2.15M | Sell |
|
|||||
|
2017
Q1 | $2.3M | Buy |
|
|||||
|
2016
Q4 | $1.89M | Sell |
|
|||||
|
2016
Q3 | $2.93M | Sell |
|
|||||
|
2016
Q2 | $3.21M | Buy |
|
|||||
|
2016
Q1 | $1.89M | Buy |
|
|||||
|
2015
Q4 | $1.32M | Sell |
|
|||||
|
2015
Q3 | $1.08M | Buy |
|
|||||
|
2015
Q2 | $1.16M | Buy |
|
|||||
|
2015
Q1 | $856K | Buy |
|
|||||
|
2014
Q4 | $379K | Sell |
|
|||||
|
2014
Q3 | $275K | Buy |
|
|||||
|
2014
Q2 | $243K | Sell |
|
|||||
|
2014
Q1 | $273K | Buy |
|
|||||
|
2013
Q4 | $149K | Sell |
|
|||||
|
2013
Q3 | $181K | Sell |
|
|||||
|
2013
Q2 | $223K | Buy |
|